Clinical Trial Update: Mite Asthma Pediatric Immunotherapy Trial [Phase 3]

View source ↗

Summary

Phase 3 pediatric immunotherapy trial for mite-induced allergic asthma has completed; results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma
• Allergic Rhinitis Due to House Dust Mite

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergic Asthma Due to Dermatophagoides Farinae, Allergic Asthma Due to Dermatophagoides Pteronyssinus | Phase 3 | Status: COMPLETED | Results posted: 2023-10-19